{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:30:39Z","timestamp":1792096239582,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virologica Sinica"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.virs.2022.07.003","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T22:07:36Z","timestamp":1657577256000},"page":"746-757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["A multiple-target mRNA-LNP vaccine induces protective immunity against experimental multi-serotype DENV in mice"],"prefix":"10.1016","volume":"37","author":[{"given":"Lihong","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1590-7380","authenticated-orcid":false,"given":"Wenjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9588-5291","authenticated-orcid":false,"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virs.2022.07.003_bib1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12934-018-0994-8","article-title":"Evaluation of cell-surface displayed synthetic consensus dengue EDIII cells as a potent oral vaccine candidate","volume":"17","author":"Bal","year":"2018","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.virs.2022.07.003_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00440-18","article-title":"Improvement of the dengue virus (DENV) nonhuman primate model via a reverse translational approach based on dengue vaccine clinical efficacy data against DENV-2 and -4","volume":"92","author":"Barban","year":"2018","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.virs.2022.07.003_bib3","doi-asserted-by":"crossref","first-page":"304ra141","DOI":"10.1126\/scitranslmed.aaa3787","article-title":"Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination","volume":"7","author":"Beatty","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.virs.2022.07.003_bib4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0264-410X(00)00040-2","article-title":"Live attenuated tetravalent dengue vaccine","volume":"18","author":"Bhamarapravati","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.virs.2022.07.003_bib5","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1903869","article-title":"Efficacy of a tetravalent dengue vaccine in healthy children and adolescents","volume":"381","author":"Biswal","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.virs.2022.07.003_bib6","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1016\/j.vaccine.2011.03.057","article-title":"Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines","volume":"29","author":"Capeding","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.virs.2022.07.003_bib7","doi-asserted-by":"crossref","first-page":"e1645","DOI":"10.1371\/journal.pntd.0001645","article-title":"Dengue-1 envelope protein domain III along with PELC and CpG oligodeoxynucleotides synergistically enhances immune responses","volume":"6","author":"Chiang","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.virs.2022.07.003_bib8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1743-422X-10-127","article-title":"Development of a transmission model for dengue virus","volume":"10","author":"Christofferson Rc","year":"2013","journal-title":"Virol. J."},{"key":"10.1016\/j.virs.2022.07.003_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.vaccine.2005.07.059","article-title":"Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence","volume":"24","author":"Costa","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.virs.2022.07.003_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3297","article-title":"Antibody-dependent enhancement (ADE) of dengue virus: identification of the key amino acid that is vital in DENV vaccine research","volume":"23","author":"Cui","year":"2021","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.virs.2022.07.003_bib11","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/s41590-021-00966-6","article-title":"Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch","volume":"22","author":"Dai","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virs.2022.07.003_bib12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s12879-016-1731-8","article-title":"Impact of dengue virus (DENV) co-infection on clinical manifestations, disease severity and laboratory parameters","volume":"16","author":"Dhanoa","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.virs.2022.07.003_bib13","doi-asserted-by":"crossref","first-page":"855","DOI":"10.4269\/ajtmh.20-0042","article-title":"Immunogenicity and safety of a tetravalent recombinant subunit dengue vaccine in adults previously vaccinated with a live attenuated tetravalent dengue vaccine: results of a phase-I randomized clinical trial","volume":"103","author":"Durbin","year":"2020","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virs.2022.07.003_bib14","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.3389\/fimmu.2019.01316","article-title":"Cross-reactive T cell immunity to dengue and Zika viruses: new insights into vaccine development","volume":"10","author":"Elong Ngono","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2022.07.003_bib15","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1016\/j.vaccine.2008.04.017","article-title":"Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies","volume":"26","author":"Golden","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.virs.2022.07.003_bib16","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/jmv.20620","article-title":"SYBR green and TaqMan real-time PCR assays are equivalent for the diagnosis of dengue virus type 3 infections","volume":"78","author":"Gomes-Ruiz","year":"2006","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.virs.2022.07.003_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/imm.13161","article-title":"Transcriptomic immune profiles of human flavivirus-specific T-cell responses","volume":"160","author":"Grifoni","year":"2020","journal-title":"Immunology"},{"key":"10.1016\/j.virs.2022.07.003_bib18","doi-asserted-by":"crossref","first-page":"7290","DOI":"10.1128\/JVI.75.16.7290-7304.2001","article-title":"Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine","volume":"75","author":"Guirakhoo","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.virs.2022.07.003_bib19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4269\/ajtmh.2009.80.302","article-title":"Evaluation of interferences between dengue vaccine serotypes in a monkey model","volume":"80","author":"Guy","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virs.2022.07.003_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1586\/erv.09.139","article-title":"Domain III of the envelope protein as a dengue vaccine target","volume":"9","author":"Guzman","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virs.2022.07.003_bib21","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1016\/j.vaccine.2018.05.028","article-title":"A\u00a0phase 1 study of safety and immunogenicity following intradermal administration of a tetravalent dengue vaccine candidate","volume":"36","author":"Jackson","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.virs.2022.07.003_bib22","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.1016\/j.vaccine.2020.08.021","article-title":"Nanodelivery system enhances the immunogenicity of dengue-2 nonstructural protein 1, DENV-2 NS1","volume":"38","author":"Jearanaiwitayakul","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.virs.2022.07.003_bib23","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1016\/j.vaccine.2017.07.045","article-title":"Immune correlates of protection for dengue: state of the art and research agenda","volume":"35","author":"Katzelnick","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.virs.2022.07.003_bib24","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1073\/pnas.1522136113","article-title":"Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort","volume":"113","author":"Katzelnick","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virs.2022.07.003_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/6803098","article-title":"Dengue fever: causes, complications, and vaccine strategies","volume":"2016","author":"Khetarpal","year":"2016","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.virs.2022.07.003_bib26","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/pbi.12869","article-title":"Plant-expressed Fc-fusion protein tetravalent dengue vaccine with inherent adjuvant properties","volume":"16","author":"Kim","year":"2018","journal-title":"Plant Biotechnol. J"},{"key":"10.1016\/j.virs.2022.07.003_bib27","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/infdis\/jiv082","article-title":"Robust and balanced immune responses to all 4 dengue virus serotypes following administration of a single dose of a live attenuated tetravalent dengue vaccine to healthy, flavivirus-naive adults","volume":"212","author":"Kirkpatrick","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.virs.2022.07.003_bib28","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/scitranslmed.aaf1517","article-title":"The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model","volume":"8","author":"Kirkpatrick","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.virs.2022.07.003_bib29","first-page":"2206","article-title":"Development and characterization of serotype-specific monoclonal antibodies against Dengue virus NS1","volume":"36","author":"Liu","year":"2020","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"key":"10.1016\/j.virs.2022.07.003_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.chom.2020.12.011","article-title":"Dengue vaccines: the promise and pitfalls of antibody-mediated protection","volume":"29","author":"Martinez","year":"2021","journal-title":"Cell. Host Microbe."},{"key":"10.1016\/j.virs.2022.07.003_bib31","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ymthe.2019.01.020","article-title":"mRNA as a transformative Technology for vaccine development to control infectious diseases","volume":"27","author":"Maruggi","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virs.2022.07.003_bib32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijid.2020.09.1446","article-title":"Dengue viremia kinetics in asymptomatic and symptomatic infection","volume":"101","author":"Matangkasombut","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.virs.2022.07.003_bib58","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1099\/jgv.0.000923","article-title":"A\u00a0lethal model of disseminated dengue virus type 1 infection in AG129 mice","volume":"98","author":"Milligan","year":"2017","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.virs.2022.07.003_bib33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4103\/ijmm.IJMM_15_536","article-title":"Co-circulation of all four dengue virus serotypes: first report from Odisha","volume":"35","author":"Mishra","year":"2017","journal-title":"Indian J. Med. Microbiol."},{"key":"10.1016\/j.virs.2022.07.003_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa3863","article-title":"Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity","volume":"7","author":"Modhiran","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.virs.2022.07.003_bib35","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s41467-021-21384-0","article-title":"A\u00a0tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humans","volume":"12","author":"Nivarthi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2022.07.003_bib36","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1021\/acs.nanolett.6b03329","article-title":"Lipid nanoparticle assisted mRNA delivery for potent cancer immunotherapy","volume":"17","author":"Oberli","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.virs.2022.07.003_bib37","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1006\/mthe.2001.0443","article-title":"VSV-G envelope glycoprotein forms complexes with plasmid DNA and MLV retrovirus-like particles in cell-free conditions and enhances DNA transfection","volume":"4","author":"Okimoto","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virs.2022.07.003_bib38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature21428","article-title":"Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination","volume":"543","author":"Pardi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.07.003_bib39","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4297\/najms.2011.3478.","article-title":"Comparison of real-time SYBR green dengue assay with real-time taqman RT-PCR dengue assay and the conventional nested PCR for diagnosis of primary and secondary dengue infection","volume":"3","author":"Paudel","year":"2011","journal-title":"N.\u00a0Am. J. Med. Sci."},{"key":"10.1016\/j.virs.2022.07.003_bib40","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/978-1-4939-0348-1_23","article-title":"Animal models in dengue","volume":"1138","author":"Plummer","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.virs.2022.07.003_bib41","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2005.11.042","article-title":"Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN","volume":"124","author":"Pokidysheva","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.virs.2022.07.003_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2021.104880","article-title":"Molecular investigation of the dengue outbreak in Karnataka, South India, reveals co-circulation of all four dengue virus serotypes","volume":"92","author":"Rai","year":"2021","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.virs.2022.07.003_bib43","series-title":"Cytotoxic T-Cells: Methods and Protocols","article-title":"CTL ELISPOT assay","author":"Ranieri","year":"2014"},{"key":"10.1016\/j.virs.2022.07.003_bib44","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2174\/092986612800191026","article-title":"Expression, purification and evaluation of diagnostic potential and immunogenicity of dengue virus type 3 domain III protein","volume":"19","author":"Reddy","year":"2012","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.virs.2022.07.003_bib45","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","article-title":"Modified mRNA vaccines protect against Zika virus infection","volume":"168","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.virs.2022.07.003_bib46","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.06.040","article-title":"Vaccine mediated protection against Zika virus-induced congenital disease","volume":"170","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.virs.2022.07.003_bib47","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3389\/fimmu.2019.01424","article-title":"A\u00a0modified mRNA vaccine targeting immunodominant NS epitopes protects against dengue virus infection in HLA class I transgenic mice","volume":"10","author":"Roth","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2022.07.003_bib48","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial","volume":"380","author":"Sabchareon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.virs.2022.07.003_bib49","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1473-3099(17)30632-1","article-title":"Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2-17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study","volume":"18","author":"S\u00e1ez-Llorens","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virs.2022.07.003_bib59","doi-asserted-by":"crossref","first-page":"7051","DOI":"10.1016\/j.vaccine.2015.09.112","article-title":"Mouse models of dengue virus infection for vaccine testing","volume":"33","author":"Sarathy","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.virs.2022.07.003_bib50","first-page":"95","article-title":"An improved method for increasing the efficiency of gene transfection and transduction","volume":"10","author":"Shi","year":"2018","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"key":"10.1016\/j.virs.2022.07.003_bib51","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/infdis\/jiv762","article-title":"Safety and immunogenicity of a tetravalent dengue vaccine candidate in healthy children and adults in dengue-endemic regions: a randomized, placebo-controlled phase 2 study","volume":"213","author":"Sirivichayakul","year":"2016","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.virs.2022.07.003_bib52","doi-asserted-by":"crossref","first-page":"e00745","DOI":"10.1128\/JVI.00745-20","article-title":"Dimerization of dengue virus E subunits impacts antibody function and domain focus","volume":"94","author":"Thomas","year":"2020","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.virs.2022.07.003_bib53","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1016\/j.celrep.2018.11.082","article-title":"An mRNA vaccine protects mice against multiple tick-transmitted flavivirus infections","volume":"25","author":"Vanblargan","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.virs.2022.07.003_bib54","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.3390\/vaccines9020148","article-title":"mRNA vaccines against flaviviruses","volume":"9","author":"Wollner","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.virs.2022.07.003_bib55","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02482-20","article-title":"A\u00a0dengue virus serotype 1 mRNA-LNP vaccine elicits protective immune responses","volume":"95","author":"Wollner","year":"2021","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.virs.2022.07.003_bib56","doi-asserted-by":"crossref","first-page":"E3351","DOI":"10.1073\/pnas.1720542115","article-title":"Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles","volume":"115","author":"Yanez Arteta","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virs.2022.07.003_bib57","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.omtm.2020.07.013","article-title":"Modified mRNA-LNP vaccines confer protection against experimental DENV-2 infection in mice","volume":"18","author":"Zhang","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.virs.2022.07.003_bib60","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.vaccine.2015.01.074","article-title":"Tetravalent dengue DIIIC protein together with alum and ODN elicits a Th1 response and neutralizing antibodies in mice","volume":"33","author":"Zuest","year":"2015","journal-title":"Vaccine"}],"container-title":["Virologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X22001171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X22001171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:18:05Z","timestamp":1761851885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1995820X22001171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1995820X22001171"],"URL":"https:\/\/doi.org\/10.1016\/j.virs.2022.07.003","relation":{},"ISSN":["1995-820X"],"issn-type":[{"value":"1995-820X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multiple-target mRNA-LNP vaccine induces protective immunity against experimental multi-serotype DENV in mice","name":"articletitle","label":"Article Title"},{"value":"Virologica Sinica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virs.2022.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}